Pfizer, Abbott India Shares Fall As Regulator Bans Codeine Cough Syrups

Shares in the Indian units of US-based drugmakers Pfizer and Abbott Laboratories fell as much as 5 per cent on Monday after authorities imposed a ban on their codeine-based cough syrups, saying they posed a health risk.
Read More